Skip to main content
Equibles

GRANDFIELD & DODD, LLC

Position in VRTX — Vertex Pharmaceuticals Inc / Ma

CIK 1308016 NEW YORK, NY
Back to VRTX Full portfolio

Position in VRTX

as of Jun 30, 2026 · filed Aug 7, 2026
Position Value
$12,337,779
+$2,646,075 QoQ
Shares Held
24,838
+14.4% QoQ
Ownership
0.010%
of shares outstanding
% of Portfolio
0.65%
of 13F equity value
Holder Rank
#335
of 1,746 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 95% Shared 0% None 5%

Common Shares in VRTX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

GRANDFIELD & DODD, LLC holds $46,143,038 across 12 Biotechnology names. VRTX ranks #2 (26.7% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 REGN
Regeneron Pharmaceuticals, Inc.
 36,628 $22,839,023
2 VRTX
Vertex Pharmaceuticals Inc / Ma
This page 		24,838 $12,337,779
3 IONS
Ionis Pharmaceuticals Inc
 37,077 $2,939,835
4 INCY
Incyte Corp
 20,822 $2,360,381
5 EXEL
Exelixis, Inc.
 27,109 $1,475,000
6 BMRN
Biomarin Pharmaceutical Inc
 18,243 $1,043,864
7 GMAB
Genmab A/S
 37,633 $1,033,778
8 ALNY
Alnylam Pharmaceuticals, Inc.
 3,204 $964,500

All Filings in VRTX

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $12,337,779 24,838
2026-03-31 $9,691,704 21,704
2025-12-31 $9,625,286 21,231
2025-09-30 $7,762,304 19,820
2025-06-30 $8,141,372 18,287
2025-03-31 $8,797,543 18,146
2024-12-31 $6,831,402 16,964
2024-09-30 $6,578,091 14,144
2024-06-30 $5,439,964 11,606
2024-03-31 $3,810,161 9,115
2023-12-31 $3,656,313 8,986
2023-09-30 $3,098,711 8,911
2023-06-30 $3,173,524 9,018
2023-03-31 $2,831,849 8,988
2022-12-31 $2,551,948 8,837
2022-09-30 $2,490,912 8,603
2022-06-30 $2,424,239 8,603
2022-03-31 $2,241,732 8,590
2021-12-31 $1,853,424 8,440
2021-09-30 $1,436,790 7,921
2021-06-30 $1,599,329 7,932
2021-03-31 $1,689,465 7,862
2020-12-31 $1,853,614 7,843
2020-09-30 $2,074,098 7,622
2020-06-30 $2,201,711 7,584
2020-03-31 $1,770,110 7,439